SomaLogic, Inc. (NASDAQ:SLGCW – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 20,800 shares, a drop of 19.7% from the January 15th total of 25,900 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is presently 1.8 days.
Institutional Trading of SomaLogic
A number of hedge funds have recently made changes to their positions in the business. Saba Capital Management L.P. acquired a new stake in shares of SomaLogic in the third quarter valued at approximately $43,000. LMR Partners LLP lifted its position in shares of SomaLogic by 64.0% in the third quarter. LMR Partners LLP now owns 573,577 shares of the company's stock valued at $1,663,000 after buying an additional 223,842 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its position in shares of SomaLogic by 4.1% in the third quarter. Point72 Asset Management L.P. now owns 1,267,427 shares of the company's stock valued at $556,000 after buying an additional 50,000 shares during the last quarter.
Get SomaLogic alerts:SomaLogic Stock Down 5.4 %
SLGCW stock opened at $0.44 on Monday. The company has a 50 day moving average of $0.47. SomaLogic has a twelve month low of $0.27 and a twelve month high of $3.44.
SomaLogic Company Profile
(Get Rating)
SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.
Read More
- Get a free copy of the StockNews.com research report on SomaLogic (SLGCW)
- MarketBeat Week in Review – 2/6 – 2/10
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with MarketBeat.com's FREE daily email newsletter.
